Name | Tumor necrosis factor receptor superfamily member 5 | ||
UniProt ID | TNR5_HUMAN | ||
Gene Name | CD40 | ||
Gene ID | 958 | ||
Synonyms |
CD40, Bp50, CDW40, TNFRSF5, p50
|
||
Sequence |
MVRLPLQCVLWGCLLTAVHPEPPTACREKQYLINSQCCSLCQPGQKLVSDCTEFTETECL
PCGESEFLDTWNRETHCHQHKYCDPNLGLRVQQKGTSETDTICTCEEGWHCTSEACESCV LHRSCSPGFGVKQIATGVSDTICEPCPVGFFSNVSSAFEKCHPWTSCETKDLVVQQAGTN KTDVVCGPQDRLRALVVIPIIFGILFAILLVLVFIKKVAKKPTNKAPHPKQEPQEINFPD DLPGSNTAAPVQETLHGCQPVTQEDGKESRISVQERQ |
||
Pathway Map | MAP LINK | ||
T.C. Number | 8.A.177.1.5; 8.A.77.1.3 | ||
KEGG ID | hsa958 | ||
TTD ID | T45758 | ||
Pfam | PF00020; PF01034; PF18278 |
Pair Name | Beta-Elemene, Fluorouracil | |||
Phytochemical | Beta-Elemene | |||
Drug | Fluorouracil | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Regulate Info | Down-regulation | Tumor necrosis factor receptor superfamily member 5 | Expression | |
Result | The conclusion obtained, considering that the results suggest that the combination may be important specifically in the treatment of TNBC. |
Pair Name | Tectochrysin, Cetuximab | |||
Phytochemical | Tectochrysin | |||
Drug | Cetuximab | |||
Disease Info | [ICD-11: 2B90.Z] | Colon cancer | Investigative | |
Regulate Info | Down-regulation | Tumor necrosis factor receptor superfamily member 5 | Expression | |
Result | Our results indicate that combined therapy with lower concentration of cetuximab and tectochrysin could significantly enhance the cancer cell growth inhibitory effect through the inhibition of EGFR signaling. |
No. | Title | Href |
---|---|---|
1 | β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways. Onco Targets Ther. 2020 Jun 9;13:5207-5222. doi: 10.2147/OTT.S242820. | Click |
2 | Synergistic inhibitory effect of cetuximab and tectochrysin on human colon cancer cell growth via inhibition of EGFR signal. Arch Pharm Res. 2016 May;39(5):721-9. doi: 10.1007/s12272-016-0735-7. | Click |